Concord Drugs Limited engages in the manufacture and sale of pharmaceutical formulations in India. It offers tissue bio-adhesive products; ready-to-fill pellets and multiple unit pellets system; other drugs in the form of tablets, capsules, small volume parenterals, dry powders, syrups and suspension, and dry syrups; and hand sanitizers. The company was incorporated in 1995 and is based in Hyderabad, India.
| Current Price | ₹38.84 |
|---|---|
| Market Cap | ₹103 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Pharmaceutical Products |
| P/E Ratio | 82 |
| Return on Equity | 2.55% |
| 52-Week Range | ₹30.59 – ₹90.08 |
| Beta (1Y) | 0.46 |
1. Pharmaceutical Products-100%
Concord Drugs Ltd is trading at ₹38.84, with a market capitalisation of ₹103 Cr.
Concord Drugs Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Products).
Concord Drugs Ltd has a P/E of 82 and a return on equity of 2.55%.